Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Jianxin Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1794-8821; OpenAlex author ID A5101711859. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway. Co-author DOI 10.1007/s10735-022-10076-8↗
  2. Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s10735-020-09934-0↗
  3. MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells. Last author DOI 10.1186/s12935-016-0331-4↗
  4. Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer. Co-author DOI 10.1007/s12032-014-0225-z↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cheng Hang · 3 shared papers, 2016–2022 · strength 0.38
  2. Gong Chen · 1 shared paper, 2022 · strength 0.15
  3. Haifeng Chen · 1 shared paper, 2022 · strength 0.15
  4. Ye Lu · 1 shared paper, 2022 · strength 0.15
  5. Hao Wang · 1 shared paper, 2016 · strength 0.06
  6. Xilong Ou · 1 shared paper, 2016 · strength 0.06
  7. Qiulan Chen · 1 shared paper, 2014 · strength 0.06
  8. Zhongmin Li · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.